Cleared Traditional

K051406 - OSTEOCURE RESORBABLE BEAD KIT

K051406 is an FDA 510(k) clearance for OSTEOCURE RESORBABLE BEAD KIT, manufactured by Nexa Orthopedics, Inc.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K051406 · Nexa Orthopedics, Inc. · Orthopedic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2005
Decision
62d
Days
Class 2
Risk

K051406 is an FDA 510(k) clearance for the OSTEOCURE RESORBABLE BEAD KIT. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Nexa Orthopedics, Inc. (Vista, US). The FDA issued a Cleared decision on August 1, 2005 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K051406

510(k) Number K051406 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 31, 2005
Decision Date August 01, 2005
Days to Decision 62 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 122d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 492
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K051406.
CONNEXUS, .5CC, MODEL 023000-005
K052098 · Isotis Orthobiologics, Inc. · Sep 2005
OSTEOMIMETIC SYNTHETIC BONE MATRIX
K051775 · Biomimetic Pharmaceuticals, Inc. · Sep 2005
STERLING CANCELLOUS CHIPS
K051615 · Regeneration Technologies, Inc. · Aug 2005
AFT
K042125 · Musculoskeletal Transplant Foundation · Jul 2005
MARROW PLUS (M+)
K051695 · Berkeley Advanced Biomaterials, Inc. · Jul 2005
CONNEXUS
K050690 · Isotis Orthobiologics, Inc. · Jul 2005
K051406 · OSTEOCURE RESORBABLE BEAD KIT
Download PDF FDA Summary Nexa Orthopedics, Inc.